Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellectis (CLLS) Accounts Payables (2016 - 2025)

Cellectis has reported Accounts Payables over the past 10 years, most recently at $17.3 million for Q4 2025.

  • Quarterly results put Accounts Payables at $17.3 million for Q4 2025, down 7.43% from a year ago — trailing twelve months through Dec 2025 was $17.3 million (down 7.43% YoY), and the annual figure for FY2025 was $17.3 million, down 7.43%.
  • Accounts Payables for Q4 2025 was $17.3 million at Cellectis, down from $18.7 million in the prior quarter.
  • Over the last five years, Accounts Payables for CLLS hit a ceiling of $23.8 million in Q4 2021 and a floor of $17.3 million in Q4 2025.
  • Median Accounts Payables over the past 5 years was $19.1 million (2023), compared with a mean of $20.0 million.
  • Biggest five-year swings in Accounts Payables: fell 11.13% in 2023 and later fell 2.12% in 2024.
  • Cellectis' Accounts Payables stood at $23.8 million in 2021, then decreased by 9.7% to $21.5 million in 2022, then fell by 11.13% to $19.1 million in 2023, then fell by 2.12% to $18.7 million in 2024, then decreased by 7.43% to $17.3 million in 2025.
  • The last three reported values for Accounts Payables were $17.3 million (Q4 2025), $18.7 million (Q4 2024), and $19.1 million (Q4 2023) per Business Quant data.